Home
E-Submission
Sitemap
Contact Us
ABOUT
Aims and scope
About the journal
Editorial board
Best practice
Open access
Contact us
BROWSE ARTICLES
All issues
Current issue
Most read articles
Most download articles
Most cited articles
Search
Author index
EDITORIAL POLICY
Research and publication ethics
Advertising policy
FOR CONTRIBUTORS
Instructions for authors
Author’s checklist
Copyright transfer agreement
Article processing charge
Readership
E-submission
Search
Previous issues
Page Path
HOME
BROWSE ARTICLES
Previous issue
Volume 13(2); Dec 2022
Review Article
자가면역결절병증
유현지, 신하영
J Mult Scler Neuroimmunol.
2022;13(2):23-29. Published online December 31, 2022
PDF
Case Reports
리툭시맙 치료로 호전된 재발 중추신경계원발혈관염 1예
김태영, 김용진, 김민, 전재현, 박현미, 신동훈, 양지원
J Mult Scler Neuroimmunol.
2022;13(2):30-34. Published online December 31, 2022
PDF
고용량 스테로이드로 치료한 무증상 COVID-19 감염 이후 파킨슨증
강유진, 구가은, 추이슬, 원문호, 박찬영
J Mult Scler Neuroimmunol.
2022;13(2):35-38. Published online December 31, 2022
PDF
Neuroimage
ANCA관련혈관염 환자에서 일측성으로 우세하게 나타난 경수막염
성의현, 김영서
J Mult Scler Neuroimmunol.
2022;13(2):39-40. Published online December 31, 2022
PDF
Journal of Multiple
Sclerosis and
Neuroimmunology
Print ISSN: 2733-8290
Online ISSN: 2951-2972
MOST VIEWED
MOST CITED
6,008
Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
2,661
Rituximab Treatment for Neuroimmunologic Disorders
2,354
National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2,324
Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
2,215
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
+more
Cited By
2
Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
+more